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1. Introduction
Head injury is the number one cause of trauma-associated mortality, being directly associated
with approximately half of all trauma-related deaths [1]. Every year in the United States,
approximately 1.5 million head injuries occur, resulting in 250,000 hospitalizations and 52,000
deaths [2]. Traumatic brain injury (TBI) is the leading cause of death in persons less than 45
years of age [3]. Furthermore, by World Health Organization estimates, TBI will be the third
leading cause of death and disability, across all age groups, by the year 2020 [4]. From a cost
perspective, TBI results in an astounding $6 billion in direct costs and over $40 billion in
indirect costs annually in the United States [5].
For neurosurgeons and intensivists involved, the management of TBI presents many chal‐
lenges. Many patients with TBI also have traumatic injury to other organ systems, further
complicating management. Centers treating a high volume of severe TBI may have better
outcomes in terms of mortality and quality of life [6].
Current management of severe TBI consists of a host of surgical and non-surgical modali‐
ties. The majority of patients with severe TBI, defined by Glascow Coma Scale (GCS) 3-8,
will  be  managed  nonsurgically.  Medical  interventions  are  generally  used  to  optimize
intracranial  pressure (ICP),  maintain cerebral  blood flow and oxygen delivery,  minimize
cerebral edema and maintain a healthy metabolic environment [7].  Surgical treatment in
severe  TBI  is  most  commonly  used  for  evacuation  of  intracranial  hemorrhage  (ICH),
especially  when there  is  decreased level  of  consciousness,  focal  neurologic  signs  and/or
evidence of  intracranial  hypertension [7].  Prior  to publication of  the “Guidelines for  the
Surgical  Management of  Traumatic  Brain Injury” in 2006,  the role  of  surgery was often
based on individual surgeon preference or subjective factors [8].  As noted by the guide‐
line  authors,  there  is  a  paucity  of  prospective,  randomized controlled trials  for  surgical
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lesions  in  TBI,  which  precluded  literature  categorization  with  traditional  “level  of  evi‐
dence” distinctions [8]. Instead, the guidelines offer “literature-based recommendations” for
the following TBI lesion types warranting surgical consideration: acute epidural hemato‐
ma (aEDH), acute subdural hematoma (aSDH), traumatic parenchymal lesions,  posterior
fossa mass lesions, and depressed cranial fractures [8].
This chapter will review the aforementioned lesion types with respect to epidemiology,
guidelines-based indications for surgery, timing, and technique. We will also review new data
pertinent to each lesion type that has been published since the 2006 “Guidelines for the Surgical
Management of Traumatic Brain Injury.” We will pay particular attention to the surgical
management of intractable intracranial hypertension, which has become the matter of intense
debate in recent years. This debate relates to the publication of the DECRA (Decompressive
Craniectomy in Diffuse Traumatic Brain Injury) trial in 2011 [9]. We will review this work in
depth, as well as, the controversy surrounding its application to patient care.
2. Acute epidural hematoma
Epidural hematoma occurs in 2.7 – 4 % of TBI patients[10]. They most frequently occur in the
temporal and temporoparietal regions as a result of linear skull fracture with subsequent
damage to either the anterior or posterior divisions of the middle meningeal artery. Traumatic
epidural hematoma of nonarterial origin may result from middle meningeal vein, diploic
emissary vein, or venous sinus bleeding and accounts for roughly 25% of total cases [11].
Epidural hematoma in patients over 65 years of age is rare, due to the prominently adhered
dura to the overlying skull. The classically described “lucid interval,” with rapid deterioration
after a period of post injury wakefulness occurs in about half of surgical cases[8]. Isolated EDH
mortality is lower than that for ASDH and approximates 10%[12]. EDH represents one of the
most urgent neurosurgical lesions, as severe brain compression can develop rapidly from high-
pressure arterial bleeding often necessitating rapid evacuation. In the appropriate patient,
surgical evacuation of posttraumatic epidural hematoma has been shown to be impressively
cost-effective with regards to quality and duration of life preserved, when compared to other
surgical procedures[13].
Guideline based indications for surgery [8]: aEDH larger than 30cc should be evacuated
regardless of the patient’s GCS score. In patients with GCS > 8 and no focal neurologic deficit,
nonoperative management with serial CT scan and close observation in a center with available
neurosurgical services can be considered if the hematoma meets the following criteria: volume
< 30cc and less than 15mm thick and < 5mm of midline shift. It is important to mention that
lesions in the temporal or posterior fossa may cause significant brainstem compression,
associated with high mortality, in the absence of large size, significant midline shift, or elevated
ICP [12,14,15]. These patients should have a much lower threshold for surgery.
Timing [8]: Patients meeting the above mentioned criteria should undergo surgical evacuation
as soon as possible. Expeditious hematoma evacuation is particularly vital for comatose
patients (GCS < 9) and/or with anisocoria.
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Surgical technique [8]: There are insufficient data to support one surgical treatment method.
Most authors would recommend craniotomy over simple burr hole evacuation in order to
provide adequate access to and evacuation of the offending clot. Traditional teaching was for
a large “question-mark” or “T” shaped incision and subsequent large trauma bone flap. With
improved imaging quality and technology, the ability to localize the clot location prior to
incision often allows for a smaller linear incision and more focused craniotomy which can be
expanded if the need arises [7]. Also common practice is to make a small dural opening in
order to inspect for a concomitant SDH which may sometimes develop with “reperfusion” or
resuscitation of the trauma patient [7].
3. Acute subdural hematoma
Acute subdural hematoma is more common than aEDH, occurring in about 30% of severely
head injured patients [16]. The most common causes of these lesions include motor vehicle
accidents, falls (particularly in those > 75 years of age) and assaults. By definition, aSDH after
trauma occurs within 14 days of injury and is associated with a higher mortality rate than EDH,
with or without surgical intervention[12,16]. Compared to isolated EDH, the degree of
underlying brain damage associated with aSDH is more severe [17]. Mortality rates tradition‐
ally quoted for those requiring surgery vary between 40 – 68% and is greatest in those with
increased age, poor initial GCS, and other associated brain and systemic injuries [12]. A recent
report observed 16% inpatient mortality for all comers with subdural hematoma, which did
not vary significantly for those undergoing surgical intervention [18].
Guideline based indications for surgery [12]: Thickness greater than 10mm or midline shift
greater than 5mm on CT should undergo surgical evacuation regardless of GCS score. Patients
with GCS < 9 should undergo intracranial pressure monitoring. For comatose patients with
less than a 10mm thick lesion or less than 5mm of midline shift, indications for surgical
evacuation include a decrease of GCS by 2 or more points, ICP > 20mmHg, or asymmetric or
fixed and dilated pupils.
Timing [12]: Most authors would agree surgical candidates should undergo evacuation as soon
as possible. This principle was originally based on a study conducted over 30 years ago
showing marked improvement in mortality if aSDH was evacuated within 4 hours of injury.
Some have since questioned this notion claiming either no outcome difference, or a worsened
outcome with more rapid time to evacuation [16,19,20]. However, a careful review of this data
reveals that the patients who underwent rapid evacuatoin also had more severe neurologic
injury prior to surgery, challenging the validity of the outcomes data [12,16,20].
Surgical technique: Craniotomy, generally via a large frontotemporoparietal approach, with
or without bone flap removal and duraplasty is the preferred technique [12]. Multiple
techniques for aSDH evacuation have been utilized in neurosurgery including trephination
via twist drill or burr hole, craniotomy +/- duraplasty, subtemporal decompressive craniecto‐
my, and large decompressive hemicraniectomy +/- duraplasty. For patients with poor GCS
associated with aSDH, trephination and irrigation without craniotomy maybe associated with
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poorer outcomes compared to craniotomy or craniectomy [12,21]. Most studies comparing
outcomes of those undergoing craniotomy vs. craniectomy suffer from selection bias as
patients with more severe injury undergo craniectomy and worse outcomes based on initial
presentation[12,22]. A subgroup of patients with a higher level of brain injury may benefit
from decompressive craniectomy [23], and it is our practice to consider decompressive
craniectomy in patients with midline shift that significantly exceeds the hematoma thickness
suggesting a greater level of associated brain injury and swelling. A ventriculostomy is placed
intraoperatively if the patient’s preoperative GCS is less than 8 or if significant swelling is
noted at the time of operation. Because brain shift is common in subdural hematoma and
external landmarks can be difficult to palpate during surgery, ventriculostomy can be quite
challenging in this setting. In addition to this, patients can also become coagulopathic in this
setting making multiple passes less desirable. In this setting, consideration should be given to
intraparenchymal ICP monitor placement if unable to successfully place a ventriculostomy.
4. Focal traumatic parenchymal lesions
Intraparenchymal hemorrhages, contusions or infarcts are associated with severe traumatic
brain injury in up to 35% of cases, but only 20% of trauma craniotomy is undertaken for their
removal [7,24-26]. These lesions occur most commonly in the frontal or temporal lobes due to
the brain impacting against the frontal bone and sphenoid ridges, whereas parietal and
occipital lobe hematoma is most often secondary to direct impact [7]. Parenchymal lesions tend
to evolve over time and the resulting mass effect from larger lesions may lead to worsened
secondary brain injury, neurological deterioration, herniation and death [27]. In addition to
lesion blossoming, delayed traumatic intracerebral hematoma (DTICH), which occurs in areas
of radiographically normal brain on initial CT scan, may lead to delayed neurological deteri‐
oration [24,28]. It is important that any patient with abnormal findings on initial CT scan be
monitored closely for the aforementioned phenomena, which may develop subsequent to
initial physical and radiographic examination. Much work has gone into prognosticating
which patient and lesion characteristics may be prone to worse outcome. Risk factors for worse
outcome include, but are not limited to increased age, lower GCS on admission, presence of
skull fracture, absence of brainstem reflexes, status of basal cisterns on CT, ICH volume,
severity of surrounding edema, preoperative neurological deterioration, and concomitant
SDH[24]. Nonfocal lesions, specifically diffuse injury with intractable intracranial hyperten‐
sion will be discussed in the next section with indications, timing and method for surgical
management of focal parenchymal lesions reviewed now.
Guideline based indications for surgery[24]: Progressive neurological deterioration referable
to the lesion, medically refractory intracranial hypertension (see section titled Intractable
Intracranial Hypertension below for discussion) or signs of mass effect on CT should be
considered for surgical evacuation. Also considered for surgical evacuation are patients with
GCS 6-8 with frontal or temporal contusions greater than 20cm3 in volume with at least 5mm
of midline shift and/or cisternal compression on CT scan, as well as, patients with any lesion
greater than 50 cm3 in size. These indications have generally been derived by review of several
Traumatic Brain Injury208
studies which have focused on defining patient and lesion characteristics at high risk for
subsequent neurological deterioration and assume that earlier operative intervention will
improve likelihood for a more favorable outcome [12,24,29-31]. Candidates for nonoperative
management with intensive monitoring and serial imaging, include those with lesions without
significant mass effect on CT scan, no evidence for neurological compromise, and without
intracranial hypertension. Such lesions are common and generally resorb in 4 to 6 weeks by
macrophage phagocytosis and gliosis [7].
Timing and surgical technique [24]: For patients with focal lesions and the indications
mentioned above, craniotomy with evacuation of the mass lesion as soon as possible is
recommended. While stereotactic evacuation of focal posttraumatic lesions has been reported,
we do not advocate this method as the majority of these patients also have a degree of diffuse
injury with associated widespread secondary injury and a degree of cerebral edema with
intracranial hypertension [24,25,32].
5. Intractable intracranial hypertension
Cerebral edema and subsequent intracranial hypertension are a major concern in combating
the secondary injury of severe TBI [24,33]. At least 80% of severe TBI patients have elevated
ICP and this is the major cause of death in those who die [7]. Intracranial pressure monitoring
is currently recommended by clinical practice guidelines for patients with severe traumatic
brain injury who have an abnormal CT scan of the head or those with a normal CT scan who
meet other specified criteria [34]. The level II recommendation for treatment is for those with
sustained intracranial pressure greater than 20mmHg [35]. Currently recommended nonop‐
erative therapies for intracranial hypertension include head of bed elevation, hyperosmolar
therapy (mannitol and/or hypertonic saline), intubation to ensure normocarbia with only short
periods of hyperventilation as a temporizing measure if needed, analgesia, neuromuscular
paralysis, ventricular drainage, hypothermia, and barbiturate or propofol induced burst
suppression [7].
The role for surgery in the treatment of medically refractory intracranial hypertension has
become the matter of intense debate in recent years. A variety of surgical procedures have been
used for treatment of refractory intracranial hypertension, without a prominent mass lesion,
including subtemporal decompression, temporal lobectomy, and circumferential craniotomy
[24]. The two most utilized surgical procedures in this setting include the hemispheric
decompressive craniectomy and the bifrontal decompressive craniectomy; the latter originally
described by Kjellberg et al [24,36]. The 2006 “Guidelines for the Surgical Management of
Traumatic Brain Injury” support bifrontal decompressive craniectomy within 48 hours of
injury as a treatment option for patients with diffuse, medically refractory posttraumatic
cerebral edema and resultant intracranial hypertension [24]. This is based on data associating
intracranial hypertension with poor outcome and multiple studies showing that decompres‐
sive craniectomy can reliably manage intracranial hypertension [37-40]. The aforementioned
data was noted to be less than ideal as it lacked data from prospective, randomized trials [24].
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For example, particular attention was paid to the work of Polin et al, which retrospectively
evaluated outcome in 35 patients undergoing bifrontal decompressive craniectomy for
refractory posttraumatic cerebral edema, matched for age, admission GCS, sex, and maximal
ICP with historical controls selected from the Traumatic Coma Data Bank [24,40]. Pertinent
findings included favorable outcome association for surgery when performed less than 48
hours after injury compared to surgery performed longer than 48 hours after injury, especially
in patients whose ICP had not yet been sustained above 40mmHg [40]. Also, medical man‐
agement alone carried a 3.8 times relative risk of unfavorable outcome compared with
decompressive craniectomy [40]. While this work and others argued in favor of bifrontal
decompressive craniectomy as the potential intervention of choice in the proper patient,
guideline authors also noted the lack of contemporaneous controls, and called for prospective,
controlled trials to meaningfully compare outcome between surgical and nonsurgical groups
in this clinical setting [24].
It was this goal that the DECRA (Decompressive Craniectomy in Diffuse Traumatic Brain
Injury) trial was undertaken [9]. DECRA was a multicenter, randomized controlled trial
conducted in 15 hospitals in Australia, New Zealand and Saudi Arabia designed to test the
efficacy of bifrontotemporoparietal decompressive craniectomy in adults below 60 years of
age with severe TBI in whom first-tier therapeutic measures failed to control ICP above 20
mmHg per Brain Trauma Foundation guidelines recommendation [9]. Randomization to
either early decompressive craniectomy or standard medical management was undertaken for
patients with an initial GCS <8 and when ICP was > 20 mmHg for > 15 minutes. At 6 months
follow-up, 70% of patients in the craniectomy group had an unfavorable outcome vs. 51% of
patients in the standard care group (odds ratio 2.21 [95% CI 1.14-4.26]; P = 0.002) [9]. This was
despite the findings that decompressive craniectomy was associated with decreased intracra‐
nial pressure and shorter ICU stays [9]. Based on these results, the authors concluded that
decompressive craniectomy was associated with more unfavorable outcomes and that the
Australian health care system would save tens of millions of dollars by adhering to a medically-
based treatment strategy rather than aggressive surgical decompression, and they predicted
the trial would significantly alter clinical practice [38].
Many neurosurgeons and intensivists certainly did not share the aforementioned opinions of
the DECRA trial authors, which provoked strong emotional reactions and has brought the
methods and results of the trial under heavy scrutiny to explain the confounding lack of
positive results [41-44]. Perhaps the most compelling criticism pertains to the baseline
characteristics of the patients in each of the study’s groups. The number of patients with
bilateral unreactive pupils in the surgical group was nearly double that in the control group
(27% vs. 12%) [9]. After controlling for this, the differences in outcomes became non-significant
[9]. In addition to pupillary differences, radiologic findings were more severe in the surgical
group (77% vs. 67% with Marshall grade III injury) and GCS scale was lower (5 vs. 6) in the
surgical group; All of the aforementioned factors have prognostic significance [41]. The issue
of patient crossover has also been noted as a potentially confounding factor in this trial [45,46].
A total of 19 patients (4 < 72 hours after randomization and 15 > 72 hours after randomization)
in the standard care group had a decompressive craniectomy as a life saving procedure, which
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some involved in the trial believe may have eliminated equipoise for the involved neurosur‐
geons who likely felt that these patients had genuinely increased ICP [41,46]. These 19 patients
were analyzed in the standard care group as there being an intention treat [45].
In addition to the baseline differences among groups in the DECRA trial, other issues with the
trial have been raised. DECRA excluded patients with any traumatic mass lesions, greatly
reducing the number of real-world patients the data may be applicable to [42]. Secondly, some
feel that the procedure used may not be as efficacious as that originally described by Polin et
al, as the DECRA procedure did not involve division of the sagittal sinus and falx cerebri [40,
42]. Furthermore, many believe the threshold ICP elevation for inclusion in the study (spon‐
taneous increase in ICP > 20mmHg for > 15 min, continuous or intermittently, within a 1-hr
period), may have been too low and that many neurosurgeons and intensivists would not
normally consider decompressive craniectomy in patients who have an intracranial pressure
around 20mmHg for such a short time [42,43,47]. Indeed, the median ICP for both groups
during the 12 hours before randomization was 20mmHg, which is the upper limit of normal
[9,42]. Based on many of the aforementioned points, the Section on Neurotrauma and Critical
Care of the American Association of Neurological Surgeons and the Congress of Neurological
Surgeons state “that no conclusions regarding management of the use of decompressive
craniotomy in patients with traumatic brain injury should be drawn from this trial, and clinical
practice should not be changed on the basis of these results [42].”
Despite its many criticisms, DECRA does represent the first randomized clinical trial of
decompression to be completed in adult neurotrauma patients, and may “have placed us on
the first rung of the evidence-based scientific ladder [41].” The protocol for the RESCUEicp
(Randomized Evaluation of Surgery with Craniectomy for Uncontrollable Elevation of
Intracranial Pressure) differs from that of the DECRA trial in terms of intracranial pressure
threshold (> 25mmHg > 1-12 hours), decompressive craniectomy techniques allowed, timing
of surgery (any time after injury vs. within 72 hours), acceptance of contusions and duration
of follow-up (2 years) [48]. At the time of this writing, recruitment is near completion with
anxiously awaited results, which may shed more light on the heavily debated topic of where
the role of decompressive craniectomy lies in treatment of diffuse traumatic brain injury. In
the meantime, decompressive craniectomy will likely continue to be used by many for
refractory intracranial hypertension. Furthermore, the available data highlights the need for
novel ways of treating patients with TBI, whether with neuroprotective agents or regenerative
therapeutics, in addition to improved prevention initiatives [49].
6. Traumatic posterior fossa mass lesions
Compared with the aforementioned traumatic brain injuries, traumatic posterior fossa mass
lesions are rare. In a recent retrospective review of 4315 patients of hospitalized TBI patients,
only 41 (1%) were noted to have posterior fossa hematomas [50]. In these 41 patients, there
were 18 patients with posterior fossa EDH, 10 with SDH, and 17 with intracerebellar hematoma
[50]. EDH is the most common posterior fossa lesion reguiring surgery, followed by SDH and
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intracerebellar hemorrhage [7]. Though rare when compared with the incidence of supraten‐
torial traumatic lesions, timely recognition and evacuation of surgical lesions is of the utmost
importance for the patient [51]. Those caring for these patients must keep in mind that because
of the limited volume of the posterior fossa and proximity of the neighboring brainstem,
rapidly fatal deterioration can occur from obstructive hydrocephalus and brainstem compres‐
sion from an expanding hematoma. Respiratory pattern changes and sudden increases in
blood pressure may be a harbinger of impending crisis, while pupillary reflexes, ICP meas‐
urements, or altered sensorium are not reliable clues to impending herniation in this region [7].
With regards to data supporting surgery in this patient population, we must keep in mind as
stated in the 2006 guidelines, “…surgery is generally viewed as required therapy in sympto‐
matic patients with progressive dysfunction. Because of the potential adverse consequences
of withholding or delaying surgery for such patients, studies depend on retrospective analyses.
As a result, there is no Class I or Class II evidence to support recommendations for the surgical
management of these injuries [51].”
Guideline based indications for surgery [51]: Patients with mass effect on computed tomo‐
graphic (CT) scan or with neurological dysfunction or deterioration referable to the lesion
should undergo operative intervention. Mass effect on CT scan is defined as distortion,
dislocation, or obliteration of the fourth ventricle; compression or loss of visualization of the
basal cisterns, or the presence of obstructive hydrocephalus. Management by close observation
and serial imaging may be appropriate for patients with lesions with no significant mass effect
on CT scan and without signs of neurologic dysfunction.
Timing [51]: In indicated cases, surgical evacuation should be performed as soon as possible
because these patients can deteriorate rapidly, thus, worsening their prognosis.
Surgical technique: Suboccipital craniectomy is the predominant method for evacuation of
posterior fossa mass lesions [51]. Generally, a ventriculostomy catheter should be placed before
surgery for the purposes of CSF drainage and ICP reduction [7]. An important caveat to
ventriculostomy in the setting of posterior fossa lesions is that many advocate slow CSF
drainage to avoid the rare possibility of upward herniation [7,52]. Because optimal surgical
positioning involves anterior flexion of the cervical spine, absence of cervical spine fracture
must also be assured and documented. Careful attention must be paid to boney removal over
the venous sinuses, which can be a major source of bleeding complicating surgery in this
region, and should be prepared for [7]. With injuries that involve the subdural spaces and
cerebellar parenchyma, a larger decompressive craniectomy including the rim of the foramen
magnum inferior, up to the edge of the transverse sinus superiorly and laterally as far as the
digastric groove should be undertaken to provide adequate decompression [7]. For lesions
extending inferiorly with concomitant compression, the posterior arch of the atlas can also be
removed [7].
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7. Depressed cranial fractures
Depressed cranial fractures complicate up to 6% of head injuries in one series [53,54]. Com‐
pound depressed cranial fractures are depressed fractures with an overlying scalp laceration
in continuity with the fracture site and with galeal disruption, while simple depressed cranial
fractures have no galeal disruption. Besides sequalae from an associated hematoma with mass
effect, the primary clinical concern for depressed skull fractures involve their association with
infection and late seizure [54]. Depressed skull fractures overlying major venous sinuses are
generally managed nonoperatively due to high associated risks of surgery, but have also been
reported to be associated with delayed onset of intracranial hypertension [55]. As is common
with the other injury types discussed previously, there is a lack of Class I literature evaluating
indications, timing and surgical techniques which provide the best outcomes for these patients
[54]. For all open cranial fractures, prophylactic antibiotics, specifically cefazolin or pipercillin/
tazobactam for 5-7 days is generally recommended [56].
Guideline based indications for surgery [54]: Open (compound) cranial fractures depressed
greater than the thickness of the cranium should undergo operative intervention to prevent
infection. Open (compound) depressed cranial fractures may be treated nonoperatively if there
is no clinical or radiographic evidence of dural penetration, significant intracranial hematoma,
depression greater than 1 cm, frontal sinus involvement, gross cosmetic deformity, wound
infection, pneumocephalus, or gross wound contamination. Nonoperative management of
closed (simple) depressed cranial fractures is a treatment option.
With regards to frontal air sinus fractures, closed fractures, which only involve the posterior
wall  of  the  sinus,  do  not  generally  require  surgical  repair  beyond  scalp  closure  [7].
Compound frontal sinus fractures, which involve both anterior and posterior walls of the
sinus,  should  be  considered  for  surgical  exploration  and  repair  due  to  risk  of  delayed
infection and/or CSF leak [7,57].
Timing [54]: Early operation is recommended to reduce the incidence of infection.
Surgical technique [54]: Elevation and debridement is recommended as the surgical method
of choice. Primary bone fragment replacement is a surgical option in the absence of wound
infection at the time surgery. All management strategies for open (compound) depressed
fractures should include antibiotics.
8. Conclusions
Optimal outcome in severe TBI requires a coordinated effort between neurosurgeon, inten‐
sivist, nusrsing and rehabilitation to provide both surgical and nonsurgical interventions. With
regards to surgery, prompt recognition and evacuation of surgical hematomas is vital. While
surgical indications for many lesion types are based on retrospective data, the reviewed
guidelines provide us with a framework from which we can build on to optimize treatment.
The recent publication of the DECRA trial and presumed completion of the RESCUEicp trial
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provide hope that higher-level evidence may be gathered in this patient population. The roleof decompressive craniectomy in intractable intracranial hypertension continues to evolve.The RESCUEicp study hopes to address the shortcomings of the DECRA study.
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